Literature DB >> 6500509

Basement membrane production by hepatocytes in chronic liver disease.

F B Bianchi, G Biagini, G Ballardini, G Cenacchi, A Faccani, E Pisi, R Laschi, L Liotta, S Garbisa.   

Abstract

The immunohistologic distribution of fibronectin, laminin, type IV collagen and whole basement membrane was evaluated in liver biopsies from patients with chronic active liver disease. Fibronectin was consistently increased in the areas of piecemeal necrosis, portal tracts and fibrous septa. Laminin was not detected in normal liver parenchyma. In contrast, laminin positive linear basement membrane structures were prevalent in portal tracts, fibrous septa and the peripheral sinusoids of cirrhotic nodules. In areas of piecemeal necrosis, the hepatocytes, single or assembled in "rosettes", were frequently underlined by linear deposits of laminin and type IV collagen. This immunoreactivity was often polarized, being confined to the stromal side of liver cells, while the parenchymal side was negative for both proteins. Electron microscopy revealed a typical basement membrane in corresponding areas. Hepatocytes normally do not produce a basement membrane, but do so following chronic injury. We suggest that the polarized basement membrane accumulation by hepatocytes is a hallmark of hepatocyte regeneration following damage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6500509     DOI: 10.1002/hep.1840040612

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  Basement membrane proteins in the space of Disse: a reappraisal.

Authors:  M R Griffiths; S Keir; A D Burt
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

2.  Defect of Fc receptors and phenotypical changes in sinusoidal endothelial cells in human liver cirrhosis.

Authors:  H Muro; H Shirasawa; I Kosugi; S Nakamura
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

3.  Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide.

Authors:  C Hirayama; H Suzuki; A Takada; K Fujisawa; K Tanikawa; S Igarashi
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

4.  Hepatocellular expression of a novel glycoprotein with sialylated difucosyl Lex activity in the active inflammatory lesions of chronic liver disease.

Authors:  Y Okada; T Shimoe; M Muguruma; R Usumoto; T Tsuji; K Jinno; S Moriwaki; S Shin; S Hakomori
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

5.  Participation of hepatocytes on laminin gene expression during CCl4-induced liver fibrosis.

Authors:  M Motomura; I Ozaki; N Fujio; Y Setoguchi; K Yamamoto; T Kariya; T Sakai
Journal:  Gastroenterol Jpn       Date:  1990-04

6.  Changes in the alveolar connective tissue of the ageing lung. An immunohistochemical study.

Authors:  A D'Errico; P Scarani; E Colosimo; M Spina; W F Grigioni; A M Mancini
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens.

Authors:  W F Grigioni; S Garbisa; A D'Errico; P Baccarini; W G Stetler-Stevenson; L A Liotta; A M Mancini
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

8.  Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.

Authors:  Gianluigi Giannelli; Emilia Fransvea; Felice Marinosci; Carlo Bergamini; Silvia Colucci; Oronzo Schiraldi; Salvatore Antonaci
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

9.  Cellular and matrix changes in drug abuser liver sinusoids: a semiquantitative and morphometric ultrastructural study.

Authors:  M S Trigueiro de Araújo; F Gérard; P Chossegros; S Guerret; P Barlet; P Adeleine; J A Grimaud
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

10.  Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver.

Authors:  J Reichen; M Le
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.